<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02164357</url>
  </required_header>
  <id_info>
    <org_study_id>FUN-TPA-2012-01</org_study_id>
    <nct_id>NCT02164357</nct_id>
  </id_info>
  <brief_title>Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset</brief_title>
  <acronym>FUN-TPA</acronym>
  <official_title>Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset: A Prospective Cohorts Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two ways of treatment for acute ischemic stroke: an endovascular
      treatment (EVT), defined as intraarterial thrombolysis and/or mechanical thrombectomy as a
      first choice treatment versus intravenous thrombolytic therapy (IVT) only or followed by EVT
      in patients with acute ischemic stroke due to a main brain artery occlusion within 4.5 hours
      after onset. Patients treated with IVT only or with IVT followed by EVT will be analyzed
      separately.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death within 90 days after onset</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptomatic intracranial haemorrhage</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke recovery rate after discharge</measure>
    <time_frame>From onset to discharge</time_frame>
    <description>Recovery defined as a 10-fold decrease in NIHSS or NIHSS (7 days after onset or at discharge)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional recovery</measure>
    <time_frame>4.5 hours after onset</time_frame>
    <description>Modified Rankin Score (RMS) value</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">124</enrollment>
  <condition>Acute Ischaemic Stroke</condition>
  <arm_group>
    <arm_group_label>EVT</arm_group_label>
    <description>Patients receiving endovascular treatment (EVT) within 4.5 hours after onset because intravenous thrombolytic therapy (IVT) is contraindicated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVT + EVT</arm_group_label>
    <description>Patients receiving intravenous thrombolytic therapy (IVT) followed by endovascular treatment (EVT) within 4.5 hours after onset</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVT (intravenous thrombolytic therapy)</arm_group_label>
    <description>Patients that will received IVT only within 4.5 hours after onset</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EVT (endovascular treatment )</intervention_name>
    <arm_group_label>EVT</arm_group_label>
    <arm_group_label>IVT + EVT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVT (intravenous thrombolytic therapy)</intervention_name>
    <arm_group_label>IVT + EVT</arm_group_label>
    <arm_group_label>IVT (intravenous thrombolytic therapy)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients younger than 80 with acute ischemic stroke produced by a main artery oclussion
        with a NIHSS &gt; 6 (National Institute of Health Stroke Scale) receiving IVT or EVT within
        4.5 hours after onset.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  80 or less years old patients with acute stroke produced by a main artery occlusion

          -  NIHSS National Institutes of Health Stroke Scale score greater than 6 (severe
             neurological impairment)

          -  Patients receiving EVT or IVT within 4.5 hours after onset

        Exclusion Criteria:

          -  EVT or IVT contraindication

          -  Previous neurological impairment, severe concomitant disease or poor prognosis.

          -  Pregnancy or breastfeeding

          -  Known hypersensitivity to any study drugs

          -  Severe organic disease for which there is not risk compensation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Doce de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2014</study_first_submitted>
  <study_first_submitted_qc>June 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2014</study_first_posted>
  <last_update_submitted>December 17, 2015</last_update_submitted>
  <last_update_submitted_qc>December 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischaemic Stroke</keyword>
  <keyword>Main artery occlusion</keyword>
  <keyword>Endovascular treatment</keyword>
  <keyword>Intravenous Thrombolytic Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrinolytic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

